NDC 71335-1013

Acyclovir

Acyclovir

Acyclovir is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Acyclovir.

Product ID71335-1013_1dc4a821-b0d6-433c-94f4-61c1a479102a
NDC71335-1013
Product TypeHuman Prescription Drug
Proprietary NameAcyclovir
Generic NameAcyclovir
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2016-10-15
Marketing CategoryANDA / ANDA
Application NumberANDA201445
Labeler NameBryant Ranch Prepack
Substance NameACYCLOVIR
Active Ingredient Strength200 mg/1
Pharm ClassesDNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71335-1013-0

90 CAPSULE in 1 BOTTLE (71335-1013-0)
Marketing Start Date2022-03-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-1013-3 [71335101303]

Acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA201445
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-11-30

NDC 71335-1013-5 [71335101305]

Acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA201445
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-11-30

NDC 71335-1013-7 [71335101307]

Acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA201445
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-11-30

NDC 71335-1013-4 [71335101304]

Acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA201445
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-11-30

NDC 71335-1013-0 [71335101300]

Acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA201445
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-11-30

NDC 71335-1013-9 [71335101309]

Acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA201445
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-11-30

NDC 71335-1013-6 [71335101306]

Acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA201445
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-11-30

NDC 71335-1013-2 [71335101302]

Acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA201445
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-11-30

NDC 71335-1013-8 [71335101308]

Acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA201445
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-11-30

NDC 71335-1013-1 [71335101301]

Acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA201445
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-11-30

Drug Details

Active Ingredients

IngredientStrength
ACYCLOVIR200 mg/1

OpenFDA Data

SPL SET ID:1dc4a821-b0d6-433c-94f4-61c1a479102a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197310

    • Pharmacological Class

    • DNA Polymerase Inhibitors [MoA]
    • Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Nucleoside Analog [EXT]

    NDC Crossover Matching brand name "Acyclovir" or generic name "Acyclovir"

    NDCBrand NameGeneric Name
    0093-3630Acycloviracyclovir
    0093-8940AcyclovirAcyclovir
    0093-8943AcyclovirAcyclovir
    0093-8947AcyclovirAcyclovir
    0143-9657AcyclovirAcyclovir
    0143-9658AcyclovirAcyclovir
    0168-0825acycloviracyclovir
    0378-8700Acycloviracyclovir
    0378-8712AcyclovirAcyclovir
    0440-6030AcyclovirAcyclovir
    0440-7033acycloviracyclovir
    0472-0082AcyclovirAcyclovir
    0591-1159Acycloviracyclovir
    0713-0630AcyclovirAcyclovir
    0904-5789ACYCLOVIRACYCLOVIR
    0904-5790acycloviracyclovir
    10544-039Acycloviracyclovir
    10544-089Acycloviracyclovir
    10544-101AcyclovirAcyclovir
    68071-1841AcyclovirAcyclovir
    68071-3155AcyclovirAcyclovir
    68071-3222AcyclovirAcyclovir
    68071-4528AcyclovirAcyclovir
    68071-4559acycloviracyclovir
    68071-4345AcyclovirAcyclovir
    68084-109AcyclovirAcyclovir
    68084-108AcyclovirAcyclovir
    68071-4790AcyclovirAcyclovir
    68071-4799AcyclovirAcyclovir
    68084-107ACYCLOVIRACYCLOVIR
    68382-125acycloviracyclovir
    68382-049acycloviracyclovir
    68382-048acycloviracyclovir
    68382-668acycloviracyclovir
    68382-126acycloviracyclovir
    68382-792acycloviracyclovir
    68382-791acycloviracyclovir
    68382-992acycloviracyclovir
    68462-746acycloviracyclovir
    68788-6360acycloviracyclovir
    68788-0505AcyclovirAcyclovir
    68788-0504AcyclovirAcyclovir
    68788-0715AcyclovirAcyclovir
    68788-8989acycloviracyclovir
    68788-6827ACYCLOVIRACYCLOVIR
    68788-7382acycloviracyclovir
    68788-7378acycloviracyclovir
    68788-9783AcyclovirAcyclovir
    68788-7342AcyclovirAcyclovir
    68788-9690AcyclovirAcyclovir
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.